Literature DB >> 19234729

Ab initio studies of receptor interactions with AMPA ((S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid) and kainic acid (2S-(2 alpha, 3 beta, 4 beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid.

Elise Champeil1, Gloria Proni, Danielle Sapse.   

Abstract

The optimum geometries and binding energies of the complexes formed by AMPA and Kainic acid, as well as their anions with tyrosine, proline and some tripeptides are investigated with quantum chemical calculations (HF/6-31G**). It was found that receptors featuring the Tyr-Ala-Pro sequence exhibit stronger binding energies to the substrates than the Tyr-Ser-Pro and Tyr-Ser-Ser. As expected, the anions are more bound than the neutral species. This work can lead to investigations on the effect of AMPA receptors mutations on the brain functions, possibly related to criminal tendencies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234729     DOI: 10.1007/s00894-009-0460-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  8 in total

Review 1.  NMDA receptor hypofunction model of schizophrenia.

Authors:  J W Olney; J W Newcomer; N B Farber
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

Review 2.  Pharmacology of Alzheimer's disease: appraisal and prospects.

Authors:  François Sellal; André Nieoullon; Géraldine Michel; Bernard François Michel; Lucette Lacomblez; Hugo Geerts; Alexandra Delini Stula; Régis Bordet; Danièle Bentué-Ferrer; Hervé Allain
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-11       Impact factor: 2.959

3.  A subtype-selective, use-dependent inhibitor of native AMPA receptors.

Authors:  Aaron Nilsen; Pamela M England
Journal:  J Am Chem Soc       Date:  2007-03-29       Impact factor: 15.419

Review 4.  A review of earlier clinical studies on neuroprotective agents and current approaches.

Authors:  N G Wahlgren
Journal:  Int Rev Neurobiol       Date:  1997       Impact factor: 3.230

5.  5-HT(1A) receptor dysfunction in female patients with schizophrenia.

Authors:  M A Lee; H Y Meltzer
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

6.  Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.

Authors:  Vittoria Colotta; Daniela Catarzi; Flavia Varano; Ombretta Lenzi; Guido Filacchioni; Chiara Costagli; Alessandro Galli; Carla Ghelardini; Nicoletta Galeotti; Paola Gratteri; Jacopo Sgrignani; Francesca Deflorian; Stefano Moro
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

7.  Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.

Authors:  Olli T Pentikäinen; Luca Settimo; Kari Keinänen; Mark S Johnson
Journal:  Biochem Pharmacol       Date:  2003-12-15       Impact factor: 5.858

Review 8.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.